Archer Investment Corporation’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.26K | Hold |
10
| – | – | ﹤0.01% | 1018 |
|
|
2025
Q1 | $1.11K | Sell |
10
-730
| -99% | -$80.7K | ﹤0.01% | 990 |
|
|
2024
Q4 | $101K | Hold |
740
| – | – | 0.03% | 335 |
|
|
2024
Q3 | $85.3K | Buy |
740
+200
| +37% | +$23K | 0.02% | 365 |
|
|
2024
Q2 | $74.3K | Hold |
540
| – | – | 0.02% | 372 |
|
|
2024
Q1 | $74.5K | Hold |
540
| – | – | 0.02% | 365 |
|
|
2023
Q4 | $71.2K | Hold |
540
| – | – | 0.02% | 347 |
|
|
2023
Q3 | $60.8K | Buy |
540
+10
| +2% | +$1.13K | 0.02% | 357 |
|
|
2023
Q2 | $50K | Hold |
530
| – | – | 0.02% | 384 |
|
|
2023
Q1 | $51.4K | Buy |
+530
| New | +$51.4K | 0.02% | 383 |
|